Steroids and receptors in canine mammary cancer

Steroids

Volumn 71, Issue 7, 2006, Pages 541-548

  Illera, Juan C ^a   Pérez Alenza, Maria D ^a   Nieto, Ana ^b   Jiménez, Maria A ^a   Silvan, Gema ^a   Dunner, Susana ^a   Peña, Laura ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Banco de líneas celulares de Granada ^*  (Spain)

Author keywords

Canine; Hormones; Inflammatory mammary carcinoma; Malignant mammary tumors; Receptors

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTENEDIONE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTRONE SULFATE; PRASTERONE; STEROID; STEROID RECEPTOR; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DOG; ENZYME IMMUNOASSAY; FEMALE; HISTOPATHOLOGY; HORMONE DETERMINATION; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; MAMMARY GLAND; NONHUMAN; PROTEIN EXPRESSION;

ANDROGENS; ANIMALS; DOGS; ESTROGENS; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAMMARY NEOPLASMS, ANIMAL; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN;

CANIS FAMILIARIS;

EID: 33747305747     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2005.11.007     Document Type: Article

References (44)

1. Giordano S.H. Update on locally advanced breast cancer. Oncologist 8 (2003) 521-530
2. Tavassoli F.A. Inflammatory carcinoma. Infiltrating carcinomas: special types. Pathology of the breast. 2nd ed. (1999), Mc Graw-Hill, New York p. 538-41
3. Perez-Alenza M.D., Tabanera E., and Peña L. Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999). J Am Vet Med Assoc 219 (2001) 1110-1114
4. Perez-Alenza M.D., Jiménez M.A., Nieto A., and Peña L. First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases. Breast Cancer Res 6 (2004) 300-307
5. Peña L., Perez-Alenza M.D., Rodriguez-Bertos A., and Nieto A. Canine inflammatory mammary carcinoma. Histopathology, immunohistochemistry and clinical implications of 21 cases. Breast Cancer Res Treat 78 (2003) 141-148
6. Brooks H.L., Mandava N., Pizzi W.F., and Shah S. Inflammatory breast carcinoma: a community hospital experience. J Am Coll Surg 186 (1998) 622-629
7. Peña L., Silvan G., Perez-Alenza M.D., Neto A., and Illera J.C. Steroid hormone profile of canine inflammatory mammary carcinoma: a preliminary study. J Steroid Biochem Mol Biol 84 (2003) 211-216
8. Nieto A., Peña L., Perez-Alenza M.D., Sanchez M.A., Flores J.M., and Castaño M. Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance. Vet Pathol 37 (2000) 239-247
9. Lantinga I.S., van Leeuwen E., van Garderen J.A., and Rutteman G.R. Cloning and cellular localization of the canine progesterone receptor: co-localization with growth hormone in the mammary gland. J Steroid Biochem Mol Biol 75 (2000) 219-228
10. Martín de las Mulas J., Ordás J., Millán M.Y., Chacón F., De Lara M., Espinosa de los Monteros A., Reymundo C., and Jover A. Immunohistochemical expression of estrogen receptor β in normal and tumoral canine mammary glands. Vet Pathol 41 (2004) 269-272
11. Misdorp W., Else R.W., Hellmén E., and Lipscomb T.P. Histological classification of mammary tumors of the dog and cat. Second series vol. 7 (1999), Armed Forces Institute of Pathology and World Health Organization, Washington
12. Kleer C.G., van Golen K.L., Zhang Y., Wu Z.F., Rubin M.A., and Merajver S.D. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am J Pathol 160 (2002) 579-584
13. Van Golen K.L., Wu Z.F., Qiao X.T., Bao L.W., and Merajver S.D. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res 60 (2000) 5832-5838
14. Labrie F., Luu-The V., Labrie C., and Simard J. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front Neuroendocrinol 22 (2001) 185-212
15. Blankenstein M.A., Van de Ven J., Maitimu-Smeele I., Donker G.H., Chr de Jong P., Daroszewski J., Szymczak J., Milewicz A., and Thijssen J.H.H. Intratumoral levels of estrogens in breast cancer. J Steroid Biochem Mol Biol 69 (1999) 293-297
16. Vermeulen A., Delyspere J.P., and Paridaens R. Steroid dynamics in the normal and carcinomatous mammary gland. J Steroid Biochem 25 (1986) 799-802
17. Killinger D.W., Perel E., Daniilescu D., Kharlip L., and Blackstein M.E. Aromatase activity in the breast and other peripheral tissues and its therapeutic regulation. Steroids 50 (1987) 523-536
18. Maggiolini M., Carpino A., Bonofiglio D., Pezzi V., Rago V., Marisco S., Picard D., and Andò S. The direct proliferative stimulus of dehydroepiandrosterone on MCF7 breast cancer cells is potentiated by overexpression of aromatase. Mol Cell Endocrinol 184 (2001) 163-171
19. Thijssen J.H.H., Blankenstein M.A., Miller W.R., and Milewicz A. Estrogens in tissues: uptake from the peripheral circulation or local production. Steroids 50 (1987) 1-3
20. Thijssen J.H.H., Blankenstein M.A., Donker G.H., and Daroszewski J. Endogenous steroid hormones and local aromatase activity in the breast. J Steroid Biochem Mol Biol 39 (1991) 799-804
21. Blankenstein M.A., Maitimu-Smeele I., Donker G.H., Daroszewski J., Milewicz A., and Thijssen J.H.H. Tissue androgens and the endocrine autonomy of breast cancer. J Steroid Biochem Mol Biol 43 (1992) 167-171
22. Liao D.J., and Dickson R.B. Roles of androgens in the development, growth, and carcinogenesis of the mammary gland. J Steroid Biochem Mol Biol 80 (2002) 175-189
23. Dimitrakakis C., Konstadoulakis M., Messaris E., Kymionis G., Karayannis M., Panoussopoulos D., Michalas S., and Androulakis G. Molecular markers in breast cancer: can we use c-erbB-2, p53, bcl-2 and bax gene expression as prognostic factors?. Breast 11 (2002) 279-285
24. Dabrosin C., Margetts P.J., and Gauldie J. Estradiol increases extracellular levels of vascular endothelial growth factor in vivo in murine mammary cancer. Int J Cancer 107 (2003) 535-540
25. Cauley J.A., Lucas F.L., Kuller L.H., Stone K., Browner W., and Cummings S.R. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Ann Intern Med 130 (1999) 270-277
26. Grace P.B., Taylor J.I., Low Y.L., Luben R.N., Mulligan A.A., Botting N.P., Dowsett M., Welch A.A., Khaw K.T., Wareham N.J., Day N.E., and Bingham S.A. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. Cancer Epidemiol Biomar Prev 13 (2004) 698-708
27. Sturgeon S.R., Potischman N., Malone K.E., Dorgan J.F., Daling J., Schairer C., and Brinton L.A. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA). Cancer Cause Control 15 (2004) 45-53
28. Key T.J., Appleby P.N., and Reeves G.K. Hormones breast cancer collaborative group. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95 (2003) 1218-1226
29. Mady E.A., Ramadan E.E.D.H., and Ossman A.A. Sex steroid hormones in serum and tissue of benign and malignant breast tumors patients. Dis Mar 16 (2000) 151-157
30. Asseryanis E., Ruecklinger E., Hellan M., Kubista E., and Singer C.F. Breast cancer size in postmenopausal women is correlated with body mass index and androgen serum levels. Gynecol Endocrinol 18 (2004) 29-36
31. Perel E., Davis S., and Killinger D.W. Androgen metabolism in male and female breast tissue. Steroids 37 (1981) 345-352
32. Chetrite G.S., Cortes-Prieto J., Philippe J.C., Wright F., and Pasqualini J.R. Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. J Steroid Biochem Mol Biol 72 (2000) 23-27
33. Santen R.J., Leszczynski D., Tilson-Mallet N., Feil P.D., Wright C., and Manni A. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways. Ann NY Acad Sci 464 (1986) 126-137
34. Pasqualini J.R., Gelly C., Nguyen B.L., and Vella C. Importance of estrogen sulfates in breast cancer. J Steroid Biochem 34 (1989) 155-163
35. Pasqualini J.R., Chetrite G., Blacker C., Feinstein M.C., Delalonde L., Talbi M., and Maloche C. Concentrations of estrone, estradiol, and estrone sulphate and evaluation of sulfatase and aromatase activities in pre- and post-menopausal breast cancer patients. J Clin Endocrinol Metab 81 (1996) 1460-1464
36. Billich A., Nussbaumer P., and Lehr P. Stimulation of MCF-7 breast cancer cell proliferation by estrone sulphate and dehydroepiandrosterone sulphate: inhibition by novel non-steroid sulfatase inhibitors. J Steroid Biochem Mol Biol 73 (2000) 225-235
37. Perel E., and Killinger D.W. The metabolism of androstenedione and testosterone to C19 metabolites in normal breast, breast carcinoma and benign prostatic hypertrophy tissue. J Steroid Biochem 29 (1983) 1135-1139
38. Brignardello E., Cassoni P., Migliardi M., Pizzini A., Di Monaco M., Boccuzzi G., and Massobrio M. Dehydroepiandrosterone concentration in breast cancer tissue is related to its plasma gradient across the mammary gland. Breast Cancer Res Treat 33 (1995) 171-177
39. Chang S., Alderfer J.R., Asmar L., and Buzdar A.U. Inflammatory breast cancer survival: the role of obesity and menopausal status at diagnosis. Breast Cancer Res Treat 64 (2000) 157-163
40. Szymczak J., Milewicz A., Thijssen JHH, Blankenstein M.A., and Daroszewski J. Concentration of sex steroids in adipose tissue after menopause. Steroids 63 (1998) 319-321
41. Wilke D., Colwell B., and Dewar R. Inflammatory breast carcinoma: comparison of survival of those diagnosed clinically, pathologically, or with both features. Am Surg 64 (1998) 428-431
42. Conde I., Alfaro J.M., Fraile B., Ruiz A., Paniagua R., and Arenas M.I. DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-alpha, ER-beta and androgen receptor status. Breast Cancer Res 6 (2004) 140-148
43. Selim A.G., El-Ayat G., and Wells C.A. Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors. J Clin Pathol 55 (2002) 14-16
44. Moinfar F., Okcu M., Tsybrovskyy O., Regitnig P., Lax S.F., Weybora W., Ratschek M., Tavassoli F.A., and Denk H. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies. Cancer 98 (2003) 703-711